Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

By PR Newswire | October 30, 2025, 8:00 AM

GAITHERSBURG, Md., Oct. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows:

Conference call details:
Date:	November 6, 2025
Time:	8:30 a.m. ET
URL to register phone:	Register Here
Dial-in number:	(888) 880-3330 (U.S.) or
	(+1) (646) 357-8766 (International)
Webcast:	ir.novavax.com/events

Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.

Replay details:
Date:	Available starting at 11:30 a.m. ET, November 6, 2025, until 11:59 p.m. ET, November 13, 2025
Dial-in number:	(800) 770-2030 (U.S.) or
	(+1) (609) 800-9909 (International)
Passcode:	3585070#
Webcast:	ir.novavax.com/events, until December 5, 2025

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M^® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors

Luis Sanay, CFA

240-268-2022

[email protected]

Media

Yvonne Sprow

844-264-8571

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-third-quarter-2025-financial-results-on-november-6-2025-302599179.html

SOURCE Novavax, Inc.

Mentioned In This Article

NVAX

-1.77%

Novavax, Inc

Latest News

Dec-08	Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock NVAX Zacks
Dec-05	Novavax, Inc. (NVAX): A Bull Case Theory NVAX Insider Monkey
Dec-02	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules NVAX Zacks
Dec-01	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 NVAX Investor's Business Daily
Dec-01	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks NVAX Investopedia
Dec-01	Nvidia's Synopsys investment, Disney stock pops on Zootopia 2 NVAX Yahoo Finance Video
Dec-01	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino NVAX Yahoo Finance Video
Dec-01	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals NVAX Barrons.com
Dec-01	Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals NVAX The Wall Street Journal
Dec-01	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths NVAX Investor's Business Daily
Dec-01	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals NVAX Barrons.com
Dec-01	Moderna Falls as FDA Vows to Impose New Vaccine Requirements NVAX Bloomberg
Dec-01	Shares of vaccine makers drop after FDA memo flags reports of child deaths NVAX Investing.com
Nov-25	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? NVAX Zacks
Nov-25	Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast NVAX Insider Monkey

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Mentioned In This Article

Latest News

Upgrade your FINVIZ experience